Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
BMC Nephrology|March 7, 2019
Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 studyChristian Combe, Johannes Mann, David Goldsmith, et al.Clinical Nephrology|November 24, 2017
Long-term treatment with biosimilar epoetin-α (HX575) in hemodialysis patients with renal anemia: real-world effectiveness and safety in the MONITOR-CKD5 studyGérard London, Johannes Mann, David Goldsmith, et al.Acta Diabetologica|November 27, 2015
RAGE and CYBA polymorphisms are associated with microalbuminuria and end-stage renal disease onset in a cohort of type 1 diabetes mellitus patients over a 20-year follow-upBenoit Franko, Pierre-Yves Benhamou, Céline Genty, et al.European Journal of Preventive Cardiology|July 15, 2025
Expert Perspectives on Incorporating GLP-1 RA in Diabetes and Chronic Kidney Disease - Challenges and OpportunitiesJean-Michel Halimi, Laurent Fauchier, Alexandre Karras, et al.Diabetes Care|December 22, 2016
Association of Circulating Biomarkers (Adrenomedullin, TNFR1, and NT-proBNP) With Renal Function Decline in Patients With Type 2 Diabetes: A French Prospective CohortPierre-Jean Saulnier, Elise Gand, Gilberto Velho, et al.Diabetes Care|October 30, 2015
Acute Kidney Injury Predicts Major Adverse Outcomes in Diabetes: Synergic Impact With Low Glomerular Filtration Rate and AlbuminuriaMathilde Monseu, Elise Gand, Pierre-Jean Saulnier, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|April 2, 2014
Conversion to mammalian target of rapamycin inhibitors increases risk of de novo donor-specific antibodiesLaure-Emmanuelle Croze, Rachel Tetaz, Matthieu Roustit, et al.International Urology and Nephrology|April 21, 2015
Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study)Loreto Gesualdo, Christian Combe, Adrian Covic, et al.Internal and Emergency Medicine|May 19, 2011
A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 studyLoreto Gesualdo, Gérard London, Matthew Turner, et al.Journal of the American Society of Nephrology : JASN|September 21, 2016
Anti-TGF-β1 Antibody Therapy in Patients with Diabetic NephropathyJames Voelker, Paul H Berg, Matthew Sheetz, et al.Pageof 5